POSB17 Ozanimod for the Treatment of Biologic-Experienced Patients with Moderate-to-Severe Ulcerative Colitis: Results from a Systematic Literature Review and Network Meta-Analyses
Abstract
Authors
K Eaton C Duperrouzel P Bhandari S Craigie A Bonner C Cameron T Tencer J Kumar